Human Gene MIR30E (uc001cgf.2) Description and Page Index
  Description: Homo sapiens microRNA 30e (MIR30E), microRNA.
RefSeq Summary (NR_029846): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: LM608676.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr1:41,220,027-41,220,118 Size: 92 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksGenetic AssociationsCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:41,220,027-41,220,118)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerHGNCLynxPubMedStanford SOURCE

-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): MIR30E
CDC HuGE Published Literature: MIR30E

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DI443408 - KR 1020140074997-A/29: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM176312 - A nucleics Acid regulating cell growth.
FV527353 - Nucleic acid controling mast cell degranulation.
FZ426775 - WO 2011019074-A/603: Nucleic acid for controlling fibrillization of cells or tissues.
HH932829 - Sequence 41 from Patent EP2239675.
HI208809 - Sequence 13 from Patent EP2041574.
HV317087 - JP 2009543862-A/13: CANCER BIOMARKERS AND METHODS OF USE THEREOF.
HV970154 - JP 2012523000-A/41: Method for in vitro Diagnosing a Complex Disease.
HW102013 - JP 2013500034-A/140: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505190 - JP 2014502606-A/92: MELANOMA TREATMENTS.
HW505198 - JP 2014502606-A/100: MELANOMA TREATMENTS.
HW807734 - JP 2014534810-A/29: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ408228 - JP 2015528002-A/825: CHIRAL CONTROL.
JA668039 - Sequence 13 from Patent WO2011139721.
JB318045 - Sequence 13 from Patent EP2442108.
JB326452 - Sequence 13 from Patent EP2450710.
JB334385 - Sequence 13 from Patent EP2442109.
JC037588 - Sequence 116 from Patent EP2643479.
LG051562 - KR 1020150036642-A/828: CHIRAL CONTROL.
LZ215751 - JP 2017518753-A/102: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
CS266362 - Sequence 54 from Patent WO2005118806.
CS266551 - Sequence 243 from Patent WO2005118806.
DL076524 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DL076713 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004174 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM004363 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261109 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763611 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421516 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421705 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304510 - JP 2009531018-A/77: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305008 - JP 2009531019-A/77: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119217 - JP 2013046612-A/77: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367387 - JP 2012228254-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367576 - JP 2012228254-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411780 - JP 2014000079-A/54: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW411969 - JP 2014000079-A/243: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589546 - JP 2013121348-A/77: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674126 - JP 2014217381-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674315 - JP 2014217381-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067068 - JP 2014012020-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067257 - JP 2014012020-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ413350 - JP 2014060993-A/77: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427492 - JP 2014217384-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427681 - JP 2014217384-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428295 - JP 2014217385-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428484 - JP 2014217385-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429098 - JP 2014217386-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429287 - JP 2014217386-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429901 - JP 2014217387-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430090 - JP 2014217387-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501561 - JP 2016025853-A/77: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769158 - JP 2014223080-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769347 - JP 2014223080-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058552 - Sequence 54 from Patent EP2298893.
JA058741 - Sequence 243 from Patent EP2298893.
JA059355 - Sequence 54 from Patent EP2298894.
JA059544 - Sequence 243 from Patent EP2298894.
JA073678 - Sequence 54 from Patent EP2281887.
JA073867 - Sequence 243 from Patent EP2281887.
JA104815 - Sequence 54 from Patent EP2302051.
JA105004 - Sequence 243 from Patent EP2302051.
JA106155 - Sequence 54 from Patent EP2302052.
JA106344 - Sequence 243 from Patent EP2302052.
JA106958 - Sequence 54 from Patent EP2302053.
JA107147 - Sequence 243 from Patent EP2302053.
JA107761 - Sequence 54 from Patent EP2302054.
JA107950 - Sequence 243 from Patent EP2302054.
JA108564 - Sequence 54 from Patent EP2302055.
JA108753 - Sequence 243 from Patent EP2302055.
JA109367 - Sequence 54 from Patent EP2302056.
JA109556 - Sequence 243 from Patent EP2302056.
JA191883 - Sequence 54 from Patent EP2290066.
JA192072 - Sequence 243 from Patent EP2290066.
JA192782 - Sequence 54 from Patent EP2290067.
JA192971 - Sequence 243 from Patent EP2290067.
JA193681 - Sequence 54 from Patent EP2290068.
JA193870 - Sequence 243 from Patent EP2290068.
JA194580 - Sequence 54 from Patent EP2290069.
JA194769 - Sequence 243 from Patent EP2290069.
JA195479 - Sequence 54 from Patent EP2290070.
JA195668 - Sequence 243 from Patent EP2290070.
JA196378 - Sequence 54 from Patent EP2290071.
JA196567 - Sequence 243 from Patent EP2290071.
JA197277 - Sequence 54 from Patent EP2290072.
JA197466 - Sequence 243 from Patent EP2290072.
JA198176 - Sequence 54 from Patent EP2290073.
JA198365 - Sequence 243 from Patent EP2290073.
JA199075 - Sequence 54 from Patent EP2290074.
JA199264 - Sequence 243 from Patent EP2290074.
JA199974 - Sequence 54 from Patent EP2290075.
JA200163 - Sequence 243 from Patent EP2290075.
JA200873 - Sequence 54 from Patent EP2290076.
JA201062 - Sequence 243 from Patent EP2290076.
JA217995 - Sequence 54 from Patent EP2281888.
JA218184 - Sequence 243 from Patent EP2281888.
JA226146 - Sequence 54 from Patent EP2292755.
JA226335 - Sequence 243 from Patent EP2292755.
JA229001 - Sequence 54 from Patent EP2292756.
JA229190 - Sequence 243 from Patent EP2292756.
JA257272 - Sequence 54 from Patent EP2284265.
JA257461 - Sequence 243 from Patent EP2284265.
JA278552 - Sequence 54 from Patent EP2281886.
JA278741 - Sequence 243 from Patent EP2281886.
JA284438 - Sequence 54 from Patent EP2281889.
JA284627 - Sequence 243 from Patent EP2281889.
JA292491 - Sequence 54 from Patent EP2287303.
JA292680 - Sequence 243 from Patent EP2287303.
JA317677 - Sequence 54 from Patent EP2314688.
JA317866 - Sequence 243 from Patent EP2314688.
JA374736 - Sequence 54 from Patent EP2322616.
JA374925 - Sequence 243 from Patent EP2322616.
JA525927 - Sequence 77 from Patent EP2369011.
JA526434 - Sequence 77 from Patent EP2369012.
JA526941 - Sequence 77 from Patent EP2369013.
JA535870 - Sequence 77 from Patent EP2371971.
JA787875 - Sequence 77 from Patent EP2479285.
JA788373 - Sequence 77 from Patent EP2479286.
JA810707 - Sequence 77 from Patent EP2468890.
JA811205 - Sequence 77 from Patent EP2468891.
JA811703 - Sequence 77 from Patent EP2468893.
JA812201 - Sequence 77 from Patent EP2468894.
JA812699 - Sequence 77 from Patent EP2468895.
JA813197 - Sequence 77 from Patent EP2468896.
JA813695 - Sequence 77 from Patent EP2468897.
JA814193 - Sequence 77 from Patent EP2468898.
JA814691 - Sequence 77 from Patent EP2468899.
JA816934 - Sequence 77 from Patent EP2468892.
JA825746 - Sequence 77 from Patent EP2471956.
JA826244 - Sequence 77 from Patent EP2471958.
JB024531 - Sequence 77 from Patent EP2505668.
JB025029 - Sequence 77 from Patent EP2505669.
JB079416 - Sequence 77 from Patent EP2487252.
JB079914 - Sequence 77 from Patent EP2487253.
JB080412 - Sequence 77 from Patent EP2487254.
JB080910 - Sequence 77 from Patent EP2487255.
JB081408 - Sequence 77 from Patent EP2487256.
JB081906 - Sequence 77 from Patent EP2487257.
JB082404 - Sequence 77 from Patent EP2487258.
JB082902 - Sequence 77 from Patent EP2487259.
JB083400 - Sequence 77 from Patent EP2487260.
JB083898 - Sequence 77 from Patent EP2487261.
JB084396 - Sequence 77 from Patent EP2487262.
JB084894 - Sequence 77 from Patent EP2487263.
JB087572 - Sequence 77 from Patent EP2502630.
JB147776 - Sequence 77 from Patent EP2484782.
JB148274 - Sequence 77 from Patent EP2484783.
JB152999 - Sequence 77 from Patent EP2514433.
JB153497 - Sequence 77 from Patent EP2514434.
JB622086 - Sequence 77 from Patent EP2586454.
JB622584 - Sequence 77 from Patent EP2586455.
JC001647 - Sequence 77 from Patent EP2591794.
JC221579 - Sequence 54 from Patent EP2471923.
JC221768 - Sequence 243 from Patent EP2471923.
JC268145 - Sequence 54 from Patent EP2471924.
JC268334 - Sequence 243 from Patent EP2471924.
JC340453 - Sequence 54 from Patent EP2471922.
JC340642 - Sequence 243 from Patent EP2471922.
JC469699 - Sequence 54 from Patent EP2471921.
JC469888 - Sequence 243 from Patent EP2471921.
JC990488 - Sequence 54 from Patent EP2808390.
JC990677 - Sequence 243 from Patent EP2808390.
LF714591 - JP 2016165292-A/54: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF714780 - JP 2016165292-A/243: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856525 - JP 2015142597-A/54: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LF856714 - JP 2015142597-A/243: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CS548395 - Sequence 1425 from Patent EP1777301.
DJ003825 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027104 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
FU261384 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763886 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW312136 - DETECTING NUCLEIC ACIDS.
FZ426181 - WO 2011019074-A/9: Nucleic acid for controlling fibrillization of cells or tissues.
HV304785 - JP 2009531018-A/352: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305283 - JP 2009531019-A/352: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119492 - JP 2013046612-A/352: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589821 - JP 2013121348-A/352: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413625 - JP 2014060993-A/352: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501836 - JP 2016025853-A/352: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526202 - Sequence 352 from Patent EP2369011.
JA526709 - Sequence 352 from Patent EP2369012.
JA527216 - Sequence 352 from Patent EP2369013.
JA536145 - Sequence 352 from Patent EP2371971.
JA788150 - Sequence 352 from Patent EP2479285.
JA788648 - Sequence 352 from Patent EP2479286.
JA810982 - Sequence 352 from Patent EP2468890.
JA811480 - Sequence 352 from Patent EP2468891.
JA811978 - Sequence 352 from Patent EP2468893.
JA812476 - Sequence 352 from Patent EP2468894.
JA812974 - Sequence 352 from Patent EP2468895.
JA813472 - Sequence 352 from Patent EP2468896.
JA813970 - Sequence 352 from Patent EP2468897.
JA814468 - Sequence 352 from Patent EP2468898.
JA814966 - Sequence 352 from Patent EP2468899.
JA817209 - Sequence 352 from Patent EP2468892.
JA826021 - Sequence 352 from Patent EP2471956.
JA826519 - Sequence 352 from Patent EP2471958.
JB024806 - Sequence 352 from Patent EP2505668.
JB025304 - Sequence 352 from Patent EP2505669.
JB079691 - Sequence 352 from Patent EP2487252.
JB080189 - Sequence 352 from Patent EP2487253.
JB080687 - Sequence 352 from Patent EP2487254.
JB081185 - Sequence 352 from Patent EP2487255.
JB081683 - Sequence 352 from Patent EP2487256.
JB082181 - Sequence 352 from Patent EP2487257.
JB082679 - Sequence 352 from Patent EP2487258.
JB083177 - Sequence 352 from Patent EP2487259.
JB083675 - Sequence 352 from Patent EP2487260.
JB084173 - Sequence 352 from Patent EP2487261.
JB084671 - Sequence 352 from Patent EP2487262.
JB085169 - Sequence 352 from Patent EP2487263.
JB087847 - Sequence 352 from Patent EP2502630.
JB148051 - Sequence 352 from Patent EP2484782.
JB148549 - Sequence 352 from Patent EP2484783.
JB153274 - Sequence 352 from Patent EP2514433.
JB153772 - Sequence 352 from Patent EP2514434.
JB622361 - Sequence 352 from Patent EP2586454.
JB622859 - Sequence 352 from Patent EP2586455.
JC001922 - Sequence 352 from Patent EP2591794.
JC334225 - Sequence 143 from Patent EP2487240.
LP636978 - Sequence 28 from Patent EP2848702.
DI443407 - KR 1020140074997-A/28: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM175266 - A nucleics Acid regulating cell growth.
FV527948 - Nucleic acid controling mast cell degranulation.
FW362675 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA.
FW364207 - Oligonucleotides for modulating target RNA activity.
FZ414378 - WO 2011007815-A/268: A method for screening a food which promotes production of milk having immunoregulating effect.
HH981308 - Sequence 68 from Patent EP1723162.
HI377382 - Sequence 9 from Patent EP2087135.
HI965193 - Sequence 478 from Patent WO2010139812.
HI965730 - Sequence 50 from Patent WO2010139811.
HI966596 - Sequence 50 from Patent WO2010139810.
HV593874 - JP 2010538610-A/87: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV595113 - JP 2010539959-A/494: Micromirs.
HV821906 - JP 2011140513-A/268: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV953958 - JP 2012518421-A/870: METHODS OF DETECTING LUNG CANCER.
HW055022 - JP 2012526132-A/42: LIPOPHILIC POLYNUCLEOTIDE CONJUGATES.
HW060369 - JP 2012527478-A/33: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW061437 - JP 2012529295-A/42: Chemical Modification Motifs for miRNA Inhibitors and Mimetics.
HW101909 - JP 2013500034-A/36: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW248826 - JP 2013514372-A/25: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY.
HW413612 - WO 2014003053-A/61: Method for screening pancreatic cancer and test kit therefor.
HW504694 - JP 2014503192-A/42: Base Modified Oligonucleotides.
HW505379 - JP 2014502606-A/281: MELANOMA TREATMENTS.
HW505387 - JP 2014502606-A/289: MELANOMA TREATMENTS.
HW523326 - JP 2014507123-A/111: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW807733 - JP 2014534810-A/28: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW915074 - JP 2015504655-A/32: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES.
HZ074175 - JP 2013535982-A/266: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082688 - JP 2015513906-A/45: Stem Cell Microparticles.
HZ157670 - JP 2015130862-A/494: Micromirs.
HZ186520 - JP 2015146814-A/269: Oligonucleotides for modulating target RNA activity.
HZ436469 - JP 2015529450-A/45: Stem Cell Microparticles.
HZ466314 - JP 2015531594-A/17: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480069 - JP 2015535430-A/575: TERMINALLY MODIFIED RNA.
HZ790000 - JP 2016504050-A/1745: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287354 - Sequence 36 from Patent WO2011015720.
JA401231 - Sequence 478 from Patent WO2011080318.
JA402209 - Sequence 478 from Patent WO2011080315.
JA403216 - Sequence 478 from Patent WO2011080316.
JA405847 - Sequence 478 from Patent EP2336353.
JA427361 - Sequence 694 from Patent WO2011072177.
JA429373 - Sequence 478 from Patent WO2011095623.
JA660617 - Sequence 71 from Patent WO2011131354.
JA682570 - Sequence 38 from Patent WO2011149354.
JA715088 - Sequence 870 from Patent EP2401406.
JA781914 - Sequence 25 from Patent EP2513307.
JA885481 - Sequence 111 from Patent WO2012083004.
JB023146 - Sequence 400 from Patent WO2013026684.
JB049919 - Sequence 6 from Patent WO2013020926.
JB074839 - Sequence 99 from Patent WO2012168448.
JB149193 - Sequence 268 from Patent EP2455486.
JB174997 - Sequence 29 from Patent WO2012101219.
JB233501 - Sequence 33 from Patent EP2437750.
JB256149 - Sequence 68 from Patent EP2327710.
JB615293 - Sequence 15 from Patent WO2013070079.
JB620351 - Sequence 331 from Patent WO2013063544.
JB751150 - Sequence 32 from Patent WO2013087907.
JC037520 - Sequence 48 from Patent EP2643479.
JC171673 - Sequence 45 from Patent WO2013150303.
JC244442 - Sequence 62 from Patent WO2012020308.
JC512732 - Sequence 2985 from Patent WO2014113089.
JC572484 - Sequence 45 from Patent WO2014125276.
JC582172 - Sequence 45 from Patent WO2014125277.
JE953868 - Sequence 45 from Patent WO2015052526.
JE955621 - Sequence 45 from Patent WO2015052527.
JE978626 - Sequence 71 from Patent EP2865765.
LF137373 - JP 2016507550-A/45: Method of Producing Microparticles.
LF160775 - JP 2016513950-A/841: Oligomers with improved off-target profile.
LF162338 - JP 2016513095-A/45: Stem Cell Microparticles and miRNA.
LF636366 - JP 2016519076-A/140: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF642624 - JP 2016518826-A/42: BRIDGED BICYCLIC NUCLEOSIDES.
LF857638 - JP 2015130879-A/87: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953090 - JP 2016534103-A/45: Stem Cell Microparticles and miRNA.
LG005435 - KR 1020150004822-A/45: STEM CELL MICROPARTICLES.
LG046502 - KR 1020150023687-A/47: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG053131 - KR 1020150059168-A/45: STEM CELL MICROPARTICLES.
LG134523 - KR 1020150131312-A/141: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240370 - KR 1020160035087-A/45: STEM CELL MICROPARTICLES AND MIRNA.
LP726356 - Sequence 50 from Patent EP2883966.
LP818626 - Sequence 50 from Patent EP3296406.
LP938568 - Sequence 50 from Patent EP3184651.
LP951540 - Sequence 46 from Patent WO2017157650.
LQ070320 - Sequence 644 from Patent EP2964234.
LQ278633 - Sequence 172 from Patent WO2016066288.
LQ420482 - Sequence 58 from Patent WO2016127998.
LQ422115 - Sequence 53 from Patent EP3026121.
LQ431593 - Sequence 4 from Patent WO2016133395.
LQ441092 - Sequence 99 from Patent EP3029157.
LQ500673 - Sequence 87 from Patent EP3048177.
LQ840937 - Sequence 47 from Patent EP3354734.
LV470455 - JP 2016534036-A/45: Stem Cell Microparticles and miRNA.
LV746122 - JP 2015521626-A/47: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LY405178 - KR 1020160117535-A/483: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504762 - KR 1020170035932-A/151: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233877 - JP 2017184756-A/269: Oligonucleotides for modulating target RNA activity.
LZ243043 - JP 2017525350-A/151: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260417 - JP 2017505623-A/483: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS637934 - Sequence 51 from Patent WO2017037190.
MS646864 - Sequence 7 from Patent WO2017051203.
MS673597 - Sequence 400 from Patent EP3135774.
MS816786 - Sequence 135 from Patent WO2017085287.
MS834332 - Sequence 478 from Patent EP3112479.
MS904171 - Sequence 87 from Patent EP3138926.
MS944895 - Sequence 151 from Patent EP3177739.
CS548394 - Sequence 1424 from Patent EP1777301.
FV525596 - Nucleic acid controling mast cell degranulation.
FW312135 - DETECTING NUCLEIC ACIDS.
FW364208 - Oligonucleotides for modulating target RNA activity.
FZ414223 - WO 2011007815-A/113: A method for screening a food which promotes production of milk having immunoregulating effect.
HI208810 - Sequence 14 from Patent EP2041574.
HI965192 - Sequence 477 from Patent WO2010139812.
HI966165 - Sequence 485 from Patent WO2010139811.
HI967031 - Sequence 485 from Patent WO2010139810.
HV317088 - JP 2009543862-A/14: CANCER BIOMARKERS AND METHODS OF USE THEREOF.
HV543933 - JP 2011217617-A/44: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV595114 - JP 2010539959-A/495: Micromirs.
HV821751 - JP 2011140513-A/113: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HW101961 - JP 2013500034-A/88: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW503027 - WO 2014034685-A/6: Diagnosis of Rheumatoid Arthritis by MicroRNA.
HW505540 - JP 2014502606-A/442: MELANOMA TREATMENTS.
HW505546 - JP 2014502606-A/448: MELANOMA TREATMENTS.
HW669841 - JP 2013537538-A/572: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW913464 - JP 2015504307-A/224: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074176 - JP 2013535982-A/267: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082714 - JP 2015513906-A/71: Stem Cell Microparticles.
HZ157671 - JP 2015130862-A/495: Micromirs.
HZ186521 - JP 2015146814-A/270: Oligonucleotides for modulating target RNA activity.
HZ436495 - JP 2015529450-A/71: Stem Cell Microparticles.
HZ480068 - JP 2015535430-A/574: TERMINALLY MODIFIED RNA.
HZ789999 - JP 2016504050-A/1744: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287406 - Sequence 88 from Patent WO2011015720.
JA401230 - Sequence 477 from Patent WO2011080318.
JA402208 - Sequence 477 from Patent WO2011080315.
JA403215 - Sequence 477 from Patent WO2011080316.
JA405846 - Sequence 477 from Patent EP2336353.
JA427069 - Sequence 402 from Patent WO2011072177.
JA429372 - Sequence 477 from Patent WO2011095623.
JA660601 - Sequence 55 from Patent WO2011131354.
JA668040 - Sequence 14 from Patent WO2011139721.
JA682649 - Sequence 117 from Patent WO2011149354.
JB022609 - Sequence 451 from Patent WO2013026685.
JB023209 - Sequence 463 from Patent WO2013026684.
JB075096 - Sequence 356 from Patent WO2012168448.
JB149038 - Sequence 113 from Patent EP2455486.
JB318046 - Sequence 14 from Patent EP2442108.
JB326453 - Sequence 14 from Patent EP2450710.
JB334386 - Sequence 14 from Patent EP2442109.
JB406718 - Sequence 44 from Patent WO2012072685.
JB616193 - Sequence 23 from Patent WO2013107459.
JB620352 - Sequence 332 from Patent WO2013063544.
JB778845 - Sequence 224 from Patent WO2013078283.
JB835756 - Sequence 46 from Patent WO2013057567.
JC017571 - Sequence 9 from Patent WO2013093870.
JC037776 - Sequence 304 from Patent EP2643479.
JC171699 - Sequence 71 from Patent WO2013150303.
JC244443 - Sequence 63 from Patent WO2012020308.
JC244957 - Sequence 585 from Patent WO2012020308.
JC270181 - Sequence 572 from Patent WO2012020307.
JC334224 - Sequence 142 from Patent EP2487240.
JC506111 - Sequence 130 from Patent EP2733219.
JC512731 - Sequence 2984 from Patent WO2014113089.
JC572510 - Sequence 71 from Patent WO2014125276.
JC582198 - Sequence 71 from Patent WO2014125277.
JC737535 - Sequence 130 from Patent WO2014075911.
JE953894 - Sequence 71 from Patent WO2015052526.
JE955647 - Sequence 71 from Patent WO2015052527.
JE957374 - Sequence 6 from Patent EP2889383.
JE978610 - Sequence 55 from Patent EP2865765.
LF137399 - JP 2016507550-A/71: Method of Producing Microparticles.
LF161505 - JP 2016513950-A/1571: Oligomers with improved off-target profile.
LF162364 - JP 2016513095-A/71: Stem Cell Microparticles and miRNA.
LF401865 - JP 2015502976-A/9: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF947823 - JP 2016208937-A/1: Marker and kit for detecting of intraductal papillary mucinous tumor.
LF953116 - JP 2016534103-A/71: Stem Cell Microparticles and miRNA.
LG005461 - KR 1020150004822-A/71: STEM CELL MICROPARTICLES.
LG053157 - KR 1020150059168-A/71: STEM CELL MICROPARTICLES.
LG240396 - KR 1020160035087-A/71: STEM CELL MICROPARTICLES AND MIRNA.
LP636977 - Sequence 27 from Patent EP2848702.
LP726791 - Sequence 485 from Patent EP2883966.
LP769498 - Sequence 25 from Patent EP3294910.
LP819061 - Sequence 485 from Patent EP3296406.
LP835229 - Sequence 27 from Patent WO2017108535.
LP939003 - Sequence 485 from Patent EP3184651.
LP939536 - Sequence 27 from Patent EP3184646.
LP951674 - Sequence 180 from Patent WO2017157650.
LQ070319 - Sequence 643 from Patent EP2964234.
LQ441349 - Sequence 356 from Patent EP3029157.
LV470481 - JP 2016534036-A/71: Stem Cell Microparticles and miRNA.
LV501777 - JP 2017018088-A/10: METHODS AND KITS FOR DETECTNG KAWASAKI DISEASE.
LX270638 - JP 2016056210-A/572: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY405179 - KR 1020160117535-A/484: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504793 - KR 1020170035932-A/182: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ215704 - JP 2017518753-A/55: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ231622 - JP 2017186339-A/9: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233878 - JP 2017184756-A/270: Oligonucleotides for modulating target RNA activity.
LZ243074 - JP 2017525350-A/182: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260418 - JP 2017505623-A/484: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673660 - Sequence 463 from Patent EP3135774.
MS834331 - Sequence 477 from Patent EP3112479.
MS901978 - Sequence 451 from Patent EP3156505.
MS944926 - Sequence 182 from Patent EP3177739.
MA643821 - JP 2017113010-A/1745: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731705 - JP 2017140048-A/575: TERMINALLY MODIFIED RNA.
MA643820 - JP 2017113010-A/1744: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730785 - JP 2017125065-A/572: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731704 - JP 2017140048-A/574: TERMINALLY MODIFIED RNA.
MA765560 - JP 2017514519-A/126: Small ncRNAs as biomarkers.
MA765566 - JP 2017514519-A/132: Small ncRNAs as biomarkers.
MA765590 - JP 2017514519-A/156: Small ncRNAs as biomarkers.
MA400838 - JP 2018515097-A/25: Method for Diagnosis and Prognosis of Chronic Heart Failure.
LQ955756 - Sequence 87 from Patent EP2775001.
LQ980607 - Sequence 253 from Patent WO2013050532.
MA625411 - JP 2018138044-A/17: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MP014858 - Sequence 61 from Patent WO2019016252.
MP070443 - Sequence 40 from Patent WO2018231851.
MP015477 - Sequence 680 from Patent WO2019016252.
MP075717 - Sequence 56 from Patent WO2019002265.
MA800874 - JP 2018183181-A/1745: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800873 - JP 2018183181-A/1744: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP114376 - Sequence 85 from Patent WO2019053235.
MP114365 - Sequence 74 from Patent WO2019053235.
MP129145 - Sequence 45 from Patent EP3470073.
MP162068 - Sequence 45 from Patent WO2019069093.
MP114366 - Sequence 75 from Patent WO2019053235.
MP129171 - Sequence 71 from Patent EP3470073.
MP162094 - Sequence 71 from Patent WO2019069093.
MA896104 - JP 2017217007-A/47: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MB018429 - JP 2018504915-A/58: A microRNA-based method for early detection of prostate cancer in urine samples.
MP280662 - Sequence 82 from Patent WO2019111197.
MP293259 - Sequence 13 from Patent EP3508854.
MP204164 - Sequence 5 from Patent WO2019081497.
MP283575 - Sequence 82 from Patent WO2019111198.
MP293260 - Sequence 14 from Patent EP3508854.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029846
UCSC ID: uc001cgf.2
RefSeq Accession: NR_029846

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029846.1
exon count: 1CDS single in 3' UTR: no RNA size: 92
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 92.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.